| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 08/02/2005 | US6923981 Fast dissolving orally consumable films |
| 08/02/2005 | US6923967 comprises xanthophyll/astaxanthin esterified with fatty acid |
| 08/02/2005 | US6923957 Inactivated virulence genes |
| 08/02/2005 | US6923654 Manikin and eye device apparatus, methods and articles of manufacture |
| 08/02/2005 | CA2325358C 7-¬(4'-trifluoromethyl-biphenyl-2-carbonyl)amino|-quinoline-3-carboxylic acid amides, and methods of inhibiting the secretion of apolipoprotein b |
| 08/02/2005 | CA2321639C Bicyclo[2.2.1]heptanes and related compounds |
| 08/02/2005 | CA2248968C Nasal administration of agents for treatment of delayed onset emesis |
| 08/02/2005 | CA2132537C Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists |
| 08/02/2005 | CA2102960C Method of treating colon disturbances with pharmaceutical compositions containing imidazol-1-yl compounds |
| 08/02/2005 | CA2091370C Tablets, granulates and pellets with a high active substance content for highly concentrated, solid dosage forms |
| 07/28/2005 | WO2005067914A1 Preventive or ameliorating agent for liver disease involving hepatopathy |
| 07/28/2005 | WO2004093828A3 Reverse-turn mimetics and method relating thereto |
| 07/28/2005 | WO2003072035A8 Compositions and methods for the treatment of immune related diseases |
| 07/28/2005 | US20050166274 Compositions and methods for the diagnosis and treatment of tumor |
| 07/28/2005 | US20050165232 Phenyl substituted imidaopyridines and phenyl substituted benzimidazoles |
| 07/28/2005 | US20050165118 Hypotensive agents; antiinflammatory agents; gastrointestinal disorders; autoimmune disease; 4-phenyl pinene derivatives |
| 07/28/2005 | US20050165112 metalloproteinase inhibitory activity; N-hydroxy-5-ethoxymethyloxy -2(S)-methyl-4(S)-(4-phenoxybenzoyl)aminopentanamide or a pharmaceutical acceptable salt |
| 07/28/2005 | US20050165106 Preferentially inhibit the inducible isoform of nitric oxide synthase |
| 07/28/2005 | US20050165103 for enhancing the endogenous production of interleukin-10 (IL-10) and suppressing the production of interleukin-2 in mammalian cells or tissues; inhibiting the proliferation of stimulated peripheral mononuclear cells |
| 07/28/2005 | US20050165088 Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions |
| 07/28/2005 | US20050165087 Nf-kb inhibitors |
| 07/28/2005 | US20050165086 Aminothiophene inhibitors of NF- kappa B inhibitors for treatment of diseases such as cancer or aids |
| 07/28/2005 | US20050165080 Administering a selective imidazoline receptor agonist: moxonidine, rilmenidine, 1,4-diisopropyl-2-(4,5-dihydro-1H-imidazol-2-yl)-piperazine, 1-(4,5-dihydro-1H-imidazol-2-yl)-isoquinoline; treating osteoporosis and hypertension simultaneously; perimenopausal or postmenopausal female |
| 07/28/2005 | US20050165064 Novel thiol derivative, process for producing the same and use thereof |
| 07/28/2005 | US20050165039 Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 07/28/2005 | US20050165023 Imidazo-triazine derivatives as ligands for gaba receptors |
| 07/28/2005 | US20050165019 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 07/28/2005 | US20050165017 Such as (3S)-2-[3-[(phenylacetyl)amino]-1-oxopropyl]-N-[cyano(3-phenoxyphenyl)methyl]hexahydro-3-pyridazinecarboxamide; for treatment of osteoporosis, hypercalcaemia, osteoporosis, gingival disease, arthritis, Paget's disease, and bone cancer |
| 07/28/2005 | US20050165016 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/28/2005 | US20050165011 6-[5-(6-methyl-pyridin-2-yl)-1H-[1,2,3]triazol-4-yl]-4H-benzo[1,4]oxazin-3-one, used as inhibitors of the transforming growth factor beta-signalling pathways, in particular, the phosphorylation of smad gene and proteins or activin-like kinase receptors; prophylaxis of kidney fibrosis |
| 07/28/2005 | US20050164993 Methods of treating allergic reactions |
| 07/28/2005 | US20050164988 Bisphosphate, bis-quaternary ammonium or bis-amine salt compounds that bind a Toll-like receptor; use desensitizing allergies, treating autoimmune diseases and inflammatory diseases, ischemia |
| 07/28/2005 | US20050164925 Treatment of gastroparesis |
| 07/28/2005 | US20050164368 Transgenic, grampositive bacteria comprising expression vector coding viricidal agent for use in treatment and prevention of gastrointestinal disorders in infants |
| 07/28/2005 | US20050164298 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor(ghs) |
| 07/28/2005 | US20050164267 Using caudal-1 gene (CDX-1) as diagnostic indicator of stomach or esophageal cancer; immunodiagnostics |
| 07/28/2005 | US20050164234 Antisense therapy; gene expression inhibition |
| 07/28/2005 | US20050164185 Interferon receptor variant for treatment and prevention of cell proliferative, autoimmune and viral diseases; prolonged activation of interferon beta |
| 07/28/2005 | US20050163888 dairy products containing Lactobacillus gasseri used for prophylaxis and/or therapy of gastrointestinal disorders such as ulcers |
| 07/28/2005 | US20050163778 Extracorporeal photopheresis in combination with anti-TNF treatment |
| 07/28/2005 | US20050163756 expressing a gene product in the gut of an animal by orally administering a recombinant AAV vector; effective, long-term expression systems; lactase deficiency |
| 07/28/2005 | US20050163751 Synergistic mixture with compounds such as interferon, paclitaxel or P-16; side effect reduction |
| 07/28/2005 | US20050163727 Topical, oral administration; mouthrinses; microbiocides; bactericides; prevents spread of pathogenic oral bacteria, toxins and endotoxins, and resultant inflammatory cytokines and mediators; cardiovascular disease, stroke, atherosclerosis |
| 07/28/2005 | DE10359384A1 Verwendung eines Extraktes von Aloysia triphylla als Matrixprotektor Use of an extract of Aloysia triphylla as a matrix protector |
| 07/28/2005 | CA2553781A1 Compositions comprising glycosaminoglycan and nonsteroidal anti-inflammatory drug |
| 07/28/2005 | CA2553303A1 Human hepatic progenitor cells and methods of use thereof |
| 07/28/2005 | CA2552965A1 Carboxamide derivative and use thereof |
| 07/28/2005 | CA2552471A1 Combination of crf antagonists and 5-ht 1b receptor antagonists |
| 07/28/2005 | CA2540272A1 Preventive or ameliorating agent for liver diseases associated with hepatopathy |
| 07/27/2005 | EP1557428A1 Antibodies against a human stromal derived factor (SDF) and pharmaceutical composition containing them |
| 07/27/2005 | EP1557409A1 5HT2C receptor modulators |
| 07/27/2005 | EP1557169A1 Therapeutic and/or preventive agent for dyschezia |
| 07/27/2005 | EP1557165A1 Combination drug |
| 07/27/2005 | EP1556705A2 Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 14 (gpr14) |
| 07/27/2005 | EP1556401A2 22 human secreted proteins |
| 07/27/2005 | EP1556399A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 07/27/2005 | EP1556371A2 Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor |
| 07/27/2005 | EP1556369A1 Pyridazinone-derivatives as pde4 inhibitors |
| 07/27/2005 | EP1556354A2 Therapeutic piperazine derivates useful for treating pain |
| 07/27/2005 | EP1556353A1 Diaryl compounds as monoamine reuptake inhibitors |
| 07/27/2005 | EP1556347A2 Gamma lactams as prostaglandin agonists and use thereof |
| 07/27/2005 | EP1556140A2 Novel compounds |
| 07/27/2005 | EP1556080A1 Use of convertase inhibitors in the treatment of fibrosis and scarring |
| 07/27/2005 | EP1556066A2 Compositions and methods of use for a fibroblast growth factor |
| 07/27/2005 | EP1556043A1 Amorphous form of esomeprazole salts |
| 07/27/2005 | EP1556033A1 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases |
| 07/27/2005 | EP1377573B1 Pyrazolopyridine derivatives |
| 07/27/2005 | EP1351961B1 Substituted indolines as 5-ht receptor ligands |
| 07/27/2005 | EP1339711B1 Aminothiazoles and their use as adenosine receptor antagonists |
| 07/27/2005 | EP1315723B1 The hydrochloride salt of 5[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione |
| 07/27/2005 | EP1313736B1 Condensed pyrazindione derivatives as inhibitors of pde5 |
| 07/27/2005 | EP1289559B1 Combinations of enzyme inhibitor-containing preparations and the use thereof |
| 07/27/2005 | EP1283823A4 Novel mmp-2/mmp-9 inhibitors |
| 07/27/2005 | EP1263757B1 Benzthiazoles as tnf and pde-iv inhibitors |
| 07/27/2005 | EP1237877B1 Carboxamide-substituted benzimidazol derivatives, methods for the production thereof and their use as medicaments |
| 07/27/2005 | EP1235557B1 Gastroretentive controlled release pharmaceutical dosage forms |
| 07/27/2005 | EP1107733B1 Oral liquid mucoadhesive compositions |
| 07/27/2005 | EP1077716B1 Preparation of a medicament for the treatment of gastroesophageal reflux disease |
| 07/27/2005 | EP1009402B1 Compositions and use of benzamides as anti-inflammatory agents |
| 07/27/2005 | CN2712931Y Electromagnetic cleavage device for cleavage extracting polypeptide from vegetable protein |
| 07/27/2005 | CN1647268A Carrier, method of manufacturing a carrier and an electronic device |
| 07/27/2005 | CN1646538A Topiramate salts and compositions comprising and methods of making and using the same |
| 07/27/2005 | CN1646537A Phosphorus-containing compounds & uses thereof |
| 07/27/2005 | CN1646531A Thioxanthine derivatives as myeloperoxidase inhibitors |
| 07/27/2005 | CN1646530A Nitrosated imidazopyridines |
| 07/27/2005 | CN1646526A Tropane derivatives as CCR5 modulators |
| 07/27/2005 | CN1646525A Process for 5-[[2(R)-[1(R)-[3, 5-bis(trifluoromethyl)phenyl]ethoxy]-3(S)-(4-fluorophenyl)-4-morpholinyl]methyl]-1, 2-dihydro-3H-1, 2, 4-triazol-3-one |
| 07/27/2005 | CN1646520A 1, 3, 5-triazine derivatives as ligands for human adenosine-A3 receptors |
| 07/27/2005 | CN1646516A Imidazolinylmethyl aralkylsulfonamides |
| 07/27/2005 | CN1646508A 5-substituted 1, 1-dioxo-1, 2, 5-thiazolidine-3-one derivatives as PTP ase 1B inhibitors |
| 07/27/2005 | CN1646505A Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 07/27/2005 | CN1646504A Substituted benzoxazoles and analogues as estrogenic agents |
| 07/27/2005 | CN1646502A Triazole derivatives as tachykinin receptor antagonists |
| 07/27/2005 | CN1646497A New aryl imidazoles and related compounds as C5a receptor modulators |
| 07/27/2005 | CN1646493A 5HT2C receptor modulators |
| 07/27/2005 | CN1646480A Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition |
| 07/27/2005 | CN1646163A Administration of agents for the treatment of inflammation |
| 07/27/2005 | CN1646160A Anti-alpha V beta 6 antibodies |
| 07/27/2005 | CN1646154A Albumin-fused anti-angiogenesis peptides |
| 07/27/2005 | CN1646143A Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders |